With autism spectrum disorder (ASD) affecting between 1-2% of the population and affecting all racial, ethnic, and socioeconomic groups, the condition is becoming of global importance. While the pharma industry has not yet been able to deliver a solution for this disease, the cell therapy industry is now undertaking the challenge. [Read more…]
Stem Cell Medicine Ltd. Inks Agreement with Ramot and Yeda to Create Stem Cell-Based Solutions to Neuronal Diseases
Stem Cell Medicine Signs License and Research Agreement with Ramot and Yeda to Develop Stem Cell-Based Treatments for Neuronal Diseases
Jerusalem, Israel, December 2, 2015 — Stem Cell Medicine Ltd. (SCM), Ramot at Tel Aviv University Ltd. (Ramot), and Yeda Research and Development Company Ltd. (YEDA), announced today that they have entered into a license and research funding agreement. [Read more…]
